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of the evidence on modifiable risk factors
for cognitive decline and dementia:
A population-based perspectiveThe article entitled “Summary of the evidence on modifi-
able risk factors for cognitive decline and dementia: A
population-based perspective” was published recently by
M Baumghart et al. in Alzheimer’s & Dementia on behalf
of the Alzheimer’s Association. This article succinctly re-
views the evidence for many putative modifiable risk factors
of Alzheimer’s disease (AD) and cognitive decline [1] and
concludes that there is strong evidence for some risk factors,
e.g. diabetes and obesity. However, although the article
sampled a broad range of risk factors, it was not comprehen-
sive. Considering the vast implications of this article for
practice guidelines and AD research priorities, we suggest
attention to another well-studied and modifiable risk for
AD—periodontal disease.
Periodontal disease is a chronic polymicrobial disease of
the tissues supporting the teeth. Others and we have studied
the association between AD/cognition and periodontal dis-
ease using a variety of exposure indexes, study designs,
and outcomes. In one longitudinal study of 597 subjects fol-
lowed for 32 years, there was an association (1.03, hazard
ratio [HR].1.09) between pocket depth, alveolar bone loss,
and tooth loss (indices of current and historical periodontal
disease) and cognitive decline [2,3]. Another showed that
periodontal inflammation predicted cognitive decline in
947 subjects with mild-to-moderate strength (odds ratio
[OR] 5 1.57 [95% confidence interval (CI), 1.01–2.45])
[4]. Other studies defining periodontal disease by immuno-
logic parameters [5] also show strong prediction (OR 5
HR 5 3.1; 95% CI, 1.5–6.4) [6]. Because of its convenient
assessment, the most prevalent index of periodontal expo-
sure is tooth loss (it is also the ultimate outcome of the un-
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increasing numbers of missing teeth (OR range: 1.05–
2.38) [7,8]. Together, these studies provide strong evidence
for a link between periodontal disease and AD/cognition.
Periodontal disease is thought to contribute to AD
progression through multiple mechanisms [9] including
inflammation, infection, and upregulation of the brain amy-
loid burden [10], and some of these mechanisms have been
proposed for other chronic diseases such as diabetes [11].
Notably, Sparks [5] showed that high levels of immunoglob-
ulin G antibodies to periodontal bacteria are present 10 years
before conversion to AD, indicating the importance of peri-
odontal infections in AD pathogenesis.
Periodontal disease is highly prevalent in the general pop-
ulation. In the United States, 46% of adults comprising 64.7
million people have periodontitis [12]. Thus, even low-to-
moderate size risks produce a substantial burden on the
population. Furthermore, periodontal disease can be suc-
cessfully managed, suggesting that prevention and treatment
could limit risk in a significant number of AD cases. As
Robert Stewart (2015) recognized, oral health is often over-
looked when assessing medical risks. Nevertheless, peri-
odontal disease is an established and modifiable risk for
AD, and deserves a place in this list.Acknowledgments
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